Benefit Plans | (15) Benefit Plans (a) Equity Incentive Plans The Company maintains a 2008 Equity Incentive Plan (the “2008 Plan”) and a 2014 Equity Incentive Plan (the “2014 Plan”) pursuant to which the Company has reserved shares of its common stock for issuance to its employees, directors and non-employee third parties. The 2014 Plan serves as the successor to the 2008 Plan and permits the granting of restricted stock units and other equity incentives at the discretion of the compensation committee of the Company’s board of directors (“the Committee”). No new awards have been or will be issued under the 2008 Plan since the effective date of the 2014 Plan. Outstanding awards under the 2008 Plan continue to be subject to the terms and conditions of the 2008 Plan. The number of shares of common stock reserved for issuance under the 2014 Plan may increase each calendar year, continuing through and including January 1, 2024. The number of shares added each year may be equal to the lesser of (a) four and five tenths percent (4.5%) of the number of shares of common stock of the Company issued and outstanding on the immediately preceding December 31, or (b) an amount determined by the Company’s board of directors. The Company’s board of directors approved the increase in the number of common shares in reserve for issuance under the 2014 Plan by 2,400 shares, effective January 1, 2022. As of June 30, 2022, the Company had 14,369 shares allocated to the plans, of which 1,976 shares were subject to outstanding options or awards. Generally, the Company issues previously unissued shares for the exercise of stock options or vesting of awards; however, shares previously subject to 2014 Plan grants or awards that are forfeited or net settled at exercise or release may be reissued to satisfy future issuances. The following table summarizes the changes in the number of shares available for grant under the Company’s equity incentive plans during the year ended June 30, 2022: Number of Available for grant at July 1 ,2021 10,312 January 1, 2022 Evergreen provision increase 2,400 RSUs granted (650) MSUs granted (48) Shares withheld in settlement of taxes and/or exercise price 289 Forfeitures 149 Shares removed (59) Available for grant at June 30, 2022 12,393 Shares removed represents forfeitures of shares and shares withheld in settlement of taxes and/or payment of exercise price related to grants made under the 2008 Plan. As noted above, no new awards will be issued under the 2008 Plan. Stock-based compensation expense related to stock options, restricted stock units (“RSUs”), market share units (“MSUs”) and the Employee Stock Purchase Plan (as described below) was included in the following line items in the accompanying Consolidated Statements of Operations and Comprehensive Income: Year Ended June 30, 2020 2021 2022 Cost of revenues $ 5,637 $ 7,687 $ 11,622 Sales and marketing 13,960 15,658 21,854 Research and development 7,182 10,192 18,696 General and administrative 20,714 29,515 44,030 Total stock-based compensation expense $ 47,493 $ 63,052 $ 96,202 In addition, the Company capitalized $2,397, $2,610 and $7,119 of stock-based compensation expense in its capitalized internal-use software costs in the years ended June 30, 2020, 2021 and 2022, respectively. In August 2020, the compensation committee of the Company’s board of directors approved the modification of the performance targets for vesting of the performance-based restricted stock units granted in fiscal 2020. The Company recorded $6,423 and $6,765 in stock-based compensation expense during the years ended June 30, 2021 and 2022, respectively, related to these modified performance-based restricted stock units. In March 2022, Michael Haske announced his intent to resign from his position effective September 1, 2022. In connection with his resignation, the Company’s board of directors approved a Transition and Separation Agreement and a Consulting Services Agreement whereby Mr. Haske will provide consulting services to the Company for a period of one year after the end of his employment on September 1, 2022. Pursuant to these agreements, the compensation committee of the Company's board of directors approved the modifications of certain of Mr. Haske's outstanding RSUs and MSUs to allow the awards to continue to vest after the end of his service period. As a result, the Company will record the cumulative effect of the modifications and accelerate the recognition of the remaining expense associated with certain of Mr. Haske's unmodified outstanding awards over his remaining substantive service period. The modifications of these awards did not have a material impact on the Company’s financial statements. The following table represents stock option activity during the year ended June 30, 2022: Number of Weighted Weighted Aggregate Balance at July 1, 2021 765 $ 16.06 2.4 $ 133,550 Options exercised (217) $ 10.29 Balance at June 30, 2022 548 $ 18.34 1.6 $ 85,515 Options vested and exercisable at June 30, 2022 548 $ 18.34 1.6 $ 85,515 There were no stock options granted during the years ended June 30, 2020, 2021 or 2022. The total intrinsic value of options exercised during the years ended June 30, 2020, 2021 and 2022 was $29,791, $84,072 and $51,457, respectively. The Company may also grant RSUs under the 2014 Plan with terms determined at the discretion of the Committee. RSUs generally vest over three Units Weighted RSU balance at July 1, 2021 1,388 $ 100.33 RSUs granted 650 $ 242.12 RSUs vested (567) $ 85.57 RSUs forfeited (144) $ 163.58 RSU balance at June 30, 2022 1,327 $ 168.44 At June 30, 2022, there was $90,250 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested restricted stock units granted. That cost is expected to be recognized over a weighted average period of 1.9 years. The Company also grants MSUs under the 2014 Plan with terms determined at the discretion of the Committee. The actual number of MSUs that will be eligible to vest is based on the achievement of a relative total shareholder return (“TSR”) target as compared to the TSR realized by each of the companies comprising the Russell 3000 Index over an approximately three -year period. The MSUs cliff-vest at the end of the TSR measurement period, and up to 200% of the target number of shares subject to each MSU are eligible to be earned. The following table represents market share unit activity during the year ended June 30, 2022: Units Weighted MSU balance at July 1, 2021 58 $ 178.04 MSUs granted 48 $ 361.02 MSUs forfeited (5) $ 178.04 MSU balance at June 30, 2022 101 $ 263.83 The Company estimated the grant date fair value of the MSUs using a Monte Carlo simulation model that included the following assumptions: Year Ended June 30, 2021 2022 Valuation assumptions: Expected dividend yield —% —% Expected volatility 52.0 % 47.4 - 47.5% Expected term (years) 3.04 2.92 - 3.04 Risk‑free interest rate 0.18% 0.43 - 0.47% At June 30, 2022, there was $12,764 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested MSUs. That cost is expected to be recognized over a period of 1.8 years. (b) Employee Stock Purchase Plan Under the Company’s Employee Stock Purchase Plan (“ESPP”), the Company can grant stock purchase rights to all eligible employees during specific offering periods not to exceed twenty-seven months. Each offering period will begin on the trading day closest to May 16 and November 16 of each year. Shares are purchased through employees’ payroll deductions, up to a maximum of 10% of employees’ compensation for each purchase period, at a purchase price equal to 85% of the lesser of the fair market value of the Company’s common stock at the first trading day of the applicable offering period or the purchase date. Participants may purchase up to $25 worth of common stock or 2 shares of common stock in any one year. The ESPP is considered compensatory and results in compensation expense. As of June 30, 2022, a total of 1,493 shares of common stock were reserved for future issuances under the ESPP. The number of shares of common stock reserved for issuance under the ESPP may increase each calendar year, continuing through and including January 1, 2024. The number of shares added each year may be equal to the lesser of (a) 400, (b) seventy-five one hundredths percent (0.75%) of the number of shares of common stock of the Company issued and outstanding on the immediately preceding December 31, or (c) an amount determined by the Company’s board of directors. The Company’s board of directors approved the increase in the number of common shares in reserve for issuance under the ESPP by 400 shares, effective January 1, 2022. The Company issued a total of 101 shares upon the completion of its six-month offering periods ending November 15, 2021 and May 13, 2022. The Company recorded compensation expense attributable to the ESPP of $3,235, $4,570 and $4,676 for the years ended June 30, 2020, 2021 and 2022, respectively, which is included in the summary of stock-based compensation expense above. The grant date fair value of the ESPP offering periods was estimated using the following assumptions: Year Ended June 30, 2020 2021 2022 Valuation assumptions: Expected dividend yield 0 % 0 % 0 % Expected volatility 38.6 - 72.2% 42.2 - 72.2% 31.0 - 57.5% Expected term (years) 0.5 0.5 0.5 Risk‑free interest rate 0.15 - 2.44% 0.04 - 0.15% 0.04 - 1.54% (c) 401(k) Plan The Company maintains a 401(k) plan with a matching provision that covers all eligible employees. The Company matches 50% of employees’ contributions up to 8% of their gross pay. Contributions were $7,914, $2,658 and $12,305 for the years ended June 30, 2020, 2021 and 2022, respectively. In response to the uncertainties presented by the COVID-19 pandemic, the Company temporarily suspended 401(k) plan matching contributions during the first three quarters of fiscal 2021. The Company reinstated contributions during the fourth quarter of fiscal 2021. |